Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Ann Arbor, Michigan

Cancer surgery and procedure trials in Ann Arbor, MI

54 cancer surgery and procedure studies are recruiting participants at sites in Ann Arbor as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Ann Arbor at a glance

  • 54 studies are recruiting at a site in Ann Arbor.
  • By phase: Phase 1 (2), Phase 1/2 (4), Phase 2 (20), Phase 3 (21), No phase (4), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (34), government (20).
  • By research area: Lymphoma (18), Lung Cancer (12), Breast Cancer (9), Prostate Cancer (7), Melanoma (4), Pancreatic Cancer (4).
  • Most recent update to one of these records: November 18, 2026.

Breast cancer studies recruiting in Ann Arbor

Basic details from each study's public record (the 30 most recently updated of 54). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT05564377 · updated
  2. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT06058377 · updated
  3. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05334069 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Lung cancer studies recruiting in Ann Arbor

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT06498635 · updated
  2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT04267848 · updated
  3. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT04181060 · updated
  4. Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT03191149 · updated
  5. A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT07293247 · updated
  6. Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    VA Ann Arbor Healthcare System, Ann Arbor, MI
    Registry record
    NCT02984761 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Prostate cancer studies recruiting in Ann Arbor

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT03866382 · updated
  2. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT07200830 · updated
  3. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    NRG Oncology
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT05946213 · updated
  4. Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial

    • No phase
    • Ages 50 to 75
    • Male participants
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT07526545 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Melanoma studies recruiting in Ann Arbor

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Lymphoma studies recruiting in Ann Arbor

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT03739814 · updated
  2. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    C S Mott Children's Hospital
    Registry record
    NCT06317662 · updated
  3. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT06337318 · updated
  4. Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT07892027 · updated
  5. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    C S Mott Children's Hospital
    Registry record
    NCT04726241 · updated
  6. Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT04269902 · updated
  7. A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • Ages 1 to 30
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    C S Mott Children's Hospital
    Registry record
    NCT04546399 · updated
  8. Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT04840602 · updated
  9. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    C S Mott Children's Hospital · Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05675410 · updated
  10. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    • Phase 3
    • Ages 18 to 39
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT03150693 · updated
  11. Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

    • Phase 3
    • Ages 60 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05976763 · updated
  12. Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT07215910 · updated
  13. Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05890352 · updated
  14. A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • From 366 days, up to 46 years
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    C S Mott Children's Hospital
    Registry record
    NCT06124157 · updated
  15. Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT07532525 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Ann Arbor

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT04858334 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Ask about studies near Ann Arbor

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Michigan

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call